|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Woodard GA, Jones KD and Jablons DM: Lung
cancer staging and prognosis. Cancer Treat Res. 170:47–75. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jeon JH, Kang CH, Kim HS, Seong YW, Park
IK, Kim YT and Kim JH: Video-assisted thoracoscopic lobectomy in
non-small-cell lung cancer patients with chronic obstructive
pulmonary disease is associated with lower pulmonary complications
than open lobectomy: A propensity score-matched analysis. Eur J
Cardiothorac Surg. 45:640–645. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Huang D, Fang F and Xu F: Hyperoxia
induces inflammation and regulates cytokine production in alveolar
epithelium through TLR2/4-NF-κB-dependent mechanism. Eur Rev Med
Pharmacol Sci. 20:1399–1410. 2016.PubMed/NCBI
|
|
5
|
Zuo X, Zhang J, Zhang Y, Hsu SC, Zhou D
and Guo W: Exo70 interacts with the Arp2/3 complex and regulates
cell migration. Nat Cell Biol. 8:1383–1388. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Saygideğer-Kont Y, Minas TZ, Jones H, Hour
S, Çelik H, Temel I, Han J, Atabey N, Erkizan HV, Toretsky JA, et
al: Ezrin enhances EGFR signaling and modulates erlotinib
sensitivity in non-small cell lung cancer cells. Neoplasia.
18:111–120. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hong Y, Li Z and Zhang Q: A circulating
tumor cell cluster-based model for tumor metastasis (Hypothesis).
Oncol Lett. 12:4891–4895. 2016.PubMed/NCBI
|
|
8
|
Ilie M, Hofman V, Long E, Bordone O, Selva
E, Washetine K, Marquette CH and Hofman P: Current challenges for
detection of circulating tumor cells and cell-free circulating
nucleic acids and their characterization in non-small cell lung
carcinoma patients. What is the best blood substrate for
personalized medicine? Ann Transl Med. 2:1072014.PubMed/NCBI
|
|
9
|
Reeh M, Effenberger KE, Koenig AM,
Riethdorf S, Eichstädt D, Vettorazzi E, Uzunoglu FG, Vashist YK,
Izbicki JR, Pantel K, et al: Circulating tumor cells as a biomarker
for preoperative prognostic staging in patients with EC. Ann Surg.
261:1124–1130. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fusi A, Metcalf R, Krebs M, Dive C and
Blackhall F: Clinical utility of circulating tumour cell detection
in non-small-cell lung cancer. Curr Treat Options Oncol.
14:610–622. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li H, Song P, Zou B, Liu M, Cui K, Zhou P,
Li S and Zhang B: Circulating tumor cell analyses in patients with
esophageal squamous cell carcinoma using epithelial
Marker-Dependent and-Independent approaches. Medicine (Baltimore).
94:e15652015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang Z, Xiao Y, Zhao J, Chen M, Xu Y,
Zhong W, Xing J and Wang M: Relationship between circulating tumour
cell count and prognosis following chemotherapy in patients with
advanced non-small-cell lung cancer. Respirology. 21:519–525. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lagerwaard FJ, Aaronson NK, Gundy CM,
Haasbeek CJ, Slotman BJ and Senan S: Patient-reported quality of
life after stereotactic ablative radiotherapy for early-stage lung
cancer. J Thorac Oncol. 7:1148–1154. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Donato BM, Burns L, Willey V, Cohenuram M,
Oliveria S and Yood MU: Treatment patterns in patients with
advanced breast cancer who were exposed to an anthracycline, a
taxane and capecitabine: A descriptive report. Clin Ther.
32:546–554. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Khan MS, Kirkwood A, Tsigani T,
Garcia-Hernandez J, Hartley JA, Caplin ME and Meyer T: Circulating
tumor cells as prognostic markers in neuroendocrine tumors. J Clin
Oncol. 31:365–372. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Stovold R, Blackhall F, Meredith S, Hou J,
Dive C and White A: Biomarkers for small cell lung cancer:
Neuroendocrine, epithelial and circulating tumour cells. Lung
Cancer. 76:263–268. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Reijm EA, Sieuwerts AM, Smid M, Vries JB,
Mostert B, Onstenk W, Peeters D, Dirix LY, Seynaeve CM, Jager A, et
al: An 8-gene mRNA expression profile in circulating tumor cells
predicts response to aromatase inhibitors in metastatic breast
cancer patients. BMC Cancer. 16:1232016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yu M, Bardia A, Wittner BS, Stott SL, Smas
ME, Ting DT, Isakoff SJ, Ciciliano JC, Wells MN, Shah AM, et al:
Circulating breast tumor cells exhibit dynamic changes in
epithelial and mesenchymal composition. Science. 339:580–584. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lecharpentier A, Vielh P, Perez-Moreno P,
Planchard D, Soria JC and Farace F: Detection of circulating tumour
cells with a hybrid (epithelial/mesenchymal) phenotype in patients
with metastatic non-small cell lung cancer. Br J Cancer.
105:1338–1341. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hosokawa M, Yoshikawa T, Negishi R,
Yoshino T, Koh Y, Kenmotsu H, Naito T, Takahashi T, Yamamoto N,
Kikuhara Y, et al: Microcavity array system for size-based
enrichment of circulating tumor cells from the blood of patients
with small-cell lung cancer. Anal Chem. 85:5692–5698. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Catenacci DV, Chapman CG, Xu P, Koons A,
Konda VJ, Siddiqui UD and Waxman I: Acquisition of portal venous
circulating tumor cells from patients with pancreaticobiliary
cancers by endoscopic ultrasound. Gastroenterology.
149:1794–1803.e4. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang Z, Shiratsuchi H, Palanisamy N,
Nagrath S and Ramnath N: Expanded circulating tumor cells from a
patient with ALK-positive lung cancer present with EML4-ALK
rearrangement along with resistance mutation and enable drug
sensitivity testing: A Case Study. J Thorac Oncol. 12:397–402.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hyun KA, Kwon K, Han H, Kim SI and Jung
HI: Microfluidic flow fractionation device for label-free isolation
of circulating tumor cells (CTCs) from breast cancer patients.
Biosens Bioelectron. 40:206–212. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bystricky B, Jurisova S, Karaba M, Minarik
G, Benca J, Sedlácková T, Tothova L, Vlkova B, Cierna Z, Janega P,
et al: Relationship between circulating tumor cells and tissue
plasminogen activator in patients with early breast cancer.
Anticancer Res. 37:1787–1791. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Aieta M, Facchinetti A, De Faveri S,
Manicone M, Tartarone A, Possidente L, Lerose R, Mambella G,
Calderone G, Zamarchi R, et al: Monitoring and characterization of
circulating tumor cells (CTCs) in a patient with EML4-ALK-positive
non-small cell lung cancer (NSCLC). Clin Lung Cancer. 17:e173–e177.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tsai WS, Chen JS, Shao HJ, Wu JC, Lai JM,
Lu SH, Hung TF, Chiu YC, You JF, Hsieh PS, et al: Circulating tumor
cell count correlates with colorectal neoplasm progression and is a
prognostic marker for distant metastasis in non-metastatic
patients. Sci Rep. 6:245172016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen X, Wang X, He H, Liu Z, Hu JF and Li
W: Combination of circulating tumor cells with serum
carcinoembryonic antigen enhances clinical prediction of non-small
cell lung cancer. PLoS One. 10:e01262762015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Swanson SJ, Miller DL, McKenna RJ Jr,
Howington J, Marshall MB, Yoo AC, Moore M, Gunnarsson CL and Meyers
BF: Comparing robot-assisted thoracic surgical lobectomy with
conventional video-assisted thoracic surgical lobectomy and wedge
resection: Results from a multihospital database (Premier). J
Thorac Cardiovasc Surg. 147:929–937. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ross K, Pailler E, Faugeroux V, Taylor M,
Oulhen M, Auger N, Planchard D, Soria JC, Lindsay CR, Besse B, et
al: The potential diagnostic power of circulating tumor cell
analysis for non-small-cell lung cancer. Expert Rev Mol Diagn.
15:1605–1629. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mego M, Giordano A, De Giorgi U, Masuda H,
Hsu L, Giuliano M, Fouad TM, Dawood S, Ueno NT, Valero V, et al:
Circulating tumor cells in newly diagnosed inflammatory breast
cancer. Breast Cancer Res. 17:22015. View Article : Google Scholar : PubMed/NCBI
|
